Results 31 to 40 of about 256,609 (339)

Secondary Mitral Regurgitation

Journal of the American College of Cardiology, 2015
In their review of secondary mitral regurgitation (MR), Asgar et al. [(1)][1] attribute abnormal leaflet tethering largely to apical and lateral papillary muscle displacement. To our knowledge the first comprehensive quantitative echocardiographic study of this topic was reported in 1983 [(2)][2].
Chester M. Boltwood, Pravin M. Shah
openaire   +3 more sources

Treatment of mitral regurgitation

Monaldi Archives for Chest Disease, 2017
<p class="Default">In the elderly mitral regurgitation is very frequent and surgical correction of mitral regurgitation (MR) has often a high operative risk, consequently, over the years, different percutaneous transcatheter techniques have been developed as a valid alternative to surgery.
Alberta Cifarelli, Diana Chin, Francesco De Felice, Roberto Violini   +3 more
openaire   +4 more sources

Advances in transcatheter mitral and tricuspid therapies

BMC Cardiovascular Disorders, 2020
Background While rheumatic mitral stenosis has been effectively treated percutaneously for more than 20 years, mitral and tricuspid regurgitation treatment appear as a contemporary unmet need.
Pavel Overtchouk, Nicolo Piazza, Juan Granada, Osama Soliman, Bernard Prendergast, Thomas Modine   +5 more
doaj   +1 more source

Midterm Outcomes of Pediatric Mitral Valvuloplasty for Moderate to Severe Mitral Valve Regurgitation and Associated Risk Factors for Postoperative Deterioration [PDF]

Texas Heart Institute Journal
Background: Mitral valvuloplasty is considered the best treatment for pediatric mitral valve regurgitation. The objective of this analysis was to identify risk factors for postoperative mitral valve regurgitation progression and evaluate valvuloplasty ...
Hongyuan Fu, MD, Aijun Liu, MD, Ming Yang, MD, Zeyu Liu, MD, Junwu Su, MD   +4 more
doaj   +1 more source

Disproportionate mitral regurgitation: another myth? A critical appraisal of echocardiographic assessment of functional mitral regurgitation

The International Journal of Cardiovascular Imaging, 2020
The contradictory findings of recent prospective randomized controlled trials assessing the impact of percutaneous edge-to-edge repair in patients with functional or secondary mitral regurgitation have triggered a lively discussion about an “integrated ...
A. Hagendorff, F. Knebel, A. Helfen, S. Stöbe, T. Doenst, V. Falk   +5 more
semanticscholar   +1 more source

Association of Mitral Valve Geometry at CT with Secondary Mitral Regurgitation after Transcatheter Aortic Valve Replacement in Patients with Aortic Regurgitation

Reviews in Cardiovascular Medicine
Background: The improvement rate and predictors of secondary mitral regurgitation in patients with aortic regurgitation undergoing transcatheter aortic valve replacement (TAVR) remain unclear.
Minyan Yin, Yuntao Lu, Xue Yang, Lili Dong, Xiaolin Wang, Lai Wei   +5 more
doaj   +1 more source

Quantitation of Mitral Regurgitation [PDF]

Circulation, 2012
Significant mitral regurgitation (MR) is estimated to afflict >2 million Americans and is anticipated to increase in prevalence as the baby boomer population ages.1 Approximately 10% of people ≥75 years of age have significant MR,1 and these patients have decreased survival regardless of whether MR is caused by a primary leaflet abnormality2 or is ...
Paul A. Grayburn, José Luis Zamorano, Neil J. Weissman   +2 more
openaire   +3 more sources

Mitral regurgitation at the time of left ventricular assist device implantation: Should it be treated or not?Central MessagePerspective

JTCVS Open
Objective: Mitral regurgitation may persist or progress after left ventricular assist device implantation. However, whether preexisting mitral regurgitation should be corrected at the time of implantation remains to be determined.
Hiroki Kohno, MD, PhD, Goro Matsumiya, MD, PhD, Yoshikatsu Saiki, MD, PhD, Koichiro Kinugawa, MD, PhD, Minoru Ono, MD, PhD   +4 more
doaj   +1 more source

Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: PRIME Study

Circulation, 2019
Background: The morbidity and mortality of patients with functional mitral regurgitation (MR) remain high, but no pharmacological therapy has been proven effective. The hypothesis of this study was that sacubitril/valsartan would be superior to valsartan
D. Kang, Sung-Ji Park, S. Shin, G. Hong, Sahmin Lee, Min-Seok Kim, S. Yun, Jong-Min Song, S. Park, Jae‐Joong Kim   +9 more
semanticscholar   +1 more source

Association between the proportionality of functional mitral regurgitation and survival after mitral valve operationCentral MessagePerspective

JTCVS Open
Objective: The concept of proportionate and disproportionate functional mitral regurgitation suggests that transcatheter edge-to-edge mitral repair may benefit patients with a smaller left ventricle relative to a higher regurgitant burden.
Makoto Mori, MD, PhD, Christina Waldron, BS, Sigurdur Ragnarsson, MD, Soh Hosoba, MD, PhD, Mina Zaky, MD, Dustin Lieu, MD, Markus Krane, MD, Arnar Geirsson, MD   +7 more
doaj   +1 more source